Dossier
AI-powered candidates
Coverage of AI-powered candidates in the Nexus archive.
- China’s drug industry pivots to AI-powered candidates to drive next wave of deals
China's drug industry is shifting focus to AI-powered drug candidates to drive future deals, following record US$110 billion in cross-border transactions for innovative drugs in the first half of 2026. China accounts for 30% of globally developed new drugs, ranking second worldwide.
- China’s drug industry pivots to AI-powered candidates to drive next wave of deals
China's cross-border deals for innovative drugs reached $110 billion in H1 2026, with the industry now focusing on AI-powered candidates to drive future transactions. China holds 30% of globally developed new drugs, ranking second worldwide, according to Lan Gongtao from the National Medical Products Administration.